Apimeds Pharmaceuticals US Inc logo

Apimeds Pharmaceuticals US Inc

APUS | AMEX
Chart Builder DCF Calculator
$2.88
-$0.33 (-10.28%)
At close: Oct 30, 2026, 3:59 PM ET
$3.14
+$0.26 (+9.03%)
Pre-market: Nov 2, 2026, 6:10 AM ET

Company Profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Key Executives

Name Position
Sungjoon Chae Co-CEO & Director
Vinod Menon Founder & Co-CEO
Amardeep Singh Chief Technology Officer
Captain Sandeep Yadav Chief Operating Officer
Erick J. Frim Chief Financial Officer
Erik C. Emerson President

Latest SEC Filings

Date Type Title
Oct 01, 2026 8-K Current Report
Sep 29, 2026 8-K Current Report
Sep 23, 2026 8-K Current Report
Sep 11, 2026 8-K Current Report
Aug 21, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 13, 2026 8-K Current Report
May 26, 2026 10-Q Quarterly Report
May 15, 2026 NT 10-Q Filing
View All SEC Filings ➞
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc logo
Country United States
IPO Date May 9, 2025
Industry Biotechnology
Sector Healthcare
Employees 7
CEO Vinod Menon

Contact Details

100 Matawan Rd Matawan, New Jersey 07747 United States

Stock Details

Ticker Symbol APUS
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001894525
CUSIP Number 03771D201
ISIN Number US03771D2018
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.